These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 6791347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [3-hydroxyanthranilic acid content in the urine of bladder cancer patients].
    Korosteleva TA, Kliucharev BV, Benteleva TA.
    Vopr Onkol; 1979; 25(6):36-9. PubMed ID: 462869
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Immunoreactivity and the effect on it of the 3-HAA antigen in patients with gastrointestinal tumors].
    Korosteleva TA, Mel'nikov RA, Belokhvostova AT, Movsesian KS, Skadova VM.
    Vopr Onkol; 1986; 32(8):38-45. PubMed ID: 3765508
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Content of 3-hydroxyanthranilic acid antigens and antibodies in mice in early stages of hepatocarcinogenesis].
    Korosteleva TA, Shvaĭdetskii II.
    Vopr Onkol; 1977; 23(6):73-8. PubMed ID: 411254
    [Abstract] [Full Text] [Related]

  • 7. [Antigen, containing tryptophan metabolite, 3-oxyanthranilic acid, in blood serum of patients with stomach neoplasms].
    Korosteleva TA, Mel'nikov RA, Belokhvostova AT.
    Vopr Onkol; 1976; 22(10):22-6. PubMed ID: 1014489
    [Abstract] [Full Text] [Related]

  • 8. [3-Hydroxyanthranilic acid in the blood of patients with kidney tumors].
    Korosteleva TA, Kliucharev BV, Belokhvostova AT.
    Vopr Onkol; 1976; 22(11):95-8. PubMed ID: 1014510
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Diagnostic significance of determining 3-hydroxyanthranilic acid in patients with precancerous diseases and cancer of the bladder].
    Klimenko IA, Romanenko AM, Korosteleva TA, Belokhvostova AT.
    Urol Nefrol (Mosk); 1986; (6):30-4. PubMed ID: 3811070
    [No Abstract] [Full Text] [Related]

  • 14. [3-HAA-antigen and immunoreactivity indices in patients with bladder tumors].
    Korosteleva TA, Rabkova LM, Belokhvostova AT, Movsesian KS, Skadova VM.
    Vopr Onkol; 1986; 32(9):48-53. PubMed ID: 3765523
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of the administration of ascorbic acid on 3-OAA-antigen levels formed during chemical hepatocarcinogenesis].
    Korosteleva TA, Shvaĭdetskiĭ II, Mishukov VI.
    Vopr Onkol; 1989; 35(12):1455-61. PubMed ID: 2609541
    [Abstract] [Full Text] [Related]

  • 17. [Detection of 3-OAA containing antigens at early stages of carcinogenesis].
    Korosteleva TA, Shvaĭdetskiĭ II.
    Vopr Onkol; 1977 Jan; 23(1):41-5. PubMed ID: 855237
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of serum lipofuscin derived from 3-hydroxyanthranilic acid in patients with chronic renal failure.
    Hegedus ZL, Frank HA, Steinman TI, Altschule MD, Nayak U.
    Arch Int Physiol Biochim; 1987 Dec; 95(5):457-63. PubMed ID: 2452619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Blastomogenic activity of 3-hydroxyanthranilic acid in dogs].
    Khrustalev SA, Khar'kovskaia NA.
    Vopr Onkol; 1980 Dec; 26(3):93-6. PubMed ID: 7368666
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.